Isabel Stückrath

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients

Corinna Eichelser, Isabel Stückrath, Volkmar Müller et al. · Oncotarget · 2014 · 376 citations · Full text

Medicine, Cancer Biology, Oncology +15

Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions

Martin L. Sos, Kathrin Michel, Thomas Zander et al. · Journal of Clinical Investigation · 2009 · 263 citations · Full text

Medicine, Molecular Biology, Oncology +17

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

Martin L. Sos, Stefanie Fischer, Roland T. Ullrich et al. · Proceedings of the National Academy of Sciences · 2009 · 256 citations · Full text

Medicine, Genetics, Oncology +17

Aberrant plasma levels of circulating<i>miR-16, miR-107, miR-130a</i>and<i>miR-146a</i>are associated with lymph node metastasis and receptor status of breast cancer patients

Isabel Stückrath, Brigitte Rack, Wolfgang Janni et al. · Oncotarget · 2015 · 104 citations · Full text

Medicine, Gynecology, Oncology +16

Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors

Carina Roth, Isabel Stückrath, Klaus Pantel et al. · PLoS ONE · 2012 · 70 citations · Full text

Medicine, Molecular Medicine, Oncology +15